Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Biological Safety Cabinet Market by Product (Class I, Class II, Class III) , by End Use (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A10258

Pages: 300

Charts: 55

Tables: 111

Biological Safety Cabinets Market Research, 2033

The global biological safety cabinets market size was valued at $202.5 million in 2023 and is projected to reach $382.2 million by 2033, growing at a CAGR of 6.7% from 2024 to 2033.

Market Introduction and Definition

A biological safety cabinet (BSC) , also known as a laminar flow or tissue culture hood, is a critical primary engineering control used to protect personnel from biohazardous or infectious agents while ensuring the quality control of materials. It operates by filtering both inflow and exhaust air, thus providing a barrier against exposure to particulates and aerosols.

BSCs are specifically designed to guard against potentially infectious aerosols and animal dander. They achieve this by recirculating a portion of the air back into the laboratory through an exhaust HEPA filter, which purifies the air effectively. However, it is important to note that while BSCs are effective in reducing exposure to biological contaminants, they do not mitigate exposure to chemical hazards. This makes them necessary in settings where biological safety is important, though additional measures are necessary for chemical safety.

Key Takeaways

  • The biological safety cabinets market forecast study covers 20 countries. The research includes a segment analysis of each country in terms of value ($million) for the projected period from 2024 to 2033.
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major energy storage system industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrates high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach intends to provide a balanced view of global markets and assist stakeholders in making informed decisions in order to achieve their most ambitious growth objectives.

 Key Market Segments

  • By Product
    • Class I
    • Class II
    • Class III
  • By End Use
    • Pharmaceutical & Biopharmaceutical Companies
    • Diagnostics & Testing Laboratories
    • Academic & Research Organizations
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of LAMEA

 
Key Market Players

  • Air Science USA LLC
  • Jinan Biobase Biotech Co. Ltd.
  • The Baker Company, Inc.
  • Germfree Laboratories, Inc.
  • Labconco Corp.
  • NuAire
  • AZBIL TELSTAR, S.L.U.
  • Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • Thermo Fisher Scientific, Inc.
  • Cruma S.A.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: BIOLOGICAL SAFETY CABINET MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Class I

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Class II

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Class III

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: BIOLOGICAL SAFETY CABINET MARKET, BY END USE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End Use

    • 5.2. Pharmaceutical And Biopharmaceutical Companies

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Diagnostics And Testing Laboratories

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Academic And Research Organizations

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: BIOLOGICAL SAFETY CABINET MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By End Use

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Biological Safety Cabinet Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By End Use

      • 6.2.6. Canada Biological Safety Cabinet Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By End Use

      • 6.2.7. Mexico Biological Safety Cabinet Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By End Use

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By End Use

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Biological Safety Cabinet Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By End Use

      • 6.3.6. Germany Biological Safety Cabinet Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By End Use

      • 6.3.7. Italy Biological Safety Cabinet Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By End Use

      • 6.3.8. Spain Biological Safety Cabinet Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By End Use

      • 6.3.9. UK Biological Safety Cabinet Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By End Use

      • 6.3.10. Russia Biological Safety Cabinet Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By End Use

      • 6.3.11. Rest Of Europe Biological Safety Cabinet Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By End Use

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By End Use

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Biological Safety Cabinet Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By End Use

      • 6.4.6. Japan Biological Safety Cabinet Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By End Use

      • 6.4.7. India Biological Safety Cabinet Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By End Use

      • 6.4.8. South Korea Biological Safety Cabinet Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By End Use

      • 6.4.9. Australia Biological Safety Cabinet Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By End Use

      • 6.4.10. Thailand Biological Safety Cabinet Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By End Use

      • 6.4.11. Malaysia Biological Safety Cabinet Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By End Use

      • 6.4.12. Indonesia Biological Safety Cabinet Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By End Use

      • 6.4.13. Rest of Asia Pacific Biological Safety Cabinet Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By End Use

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By End Use

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Biological Safety Cabinet Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By End Use

      • 6.5.6. South Africa Biological Safety Cabinet Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By End Use

      • 6.5.7. Saudi Arabia Biological Safety Cabinet Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By End Use

      • 6.5.8. UAE Biological Safety Cabinet Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By End Use

      • 6.5.9. Argentina Biological Safety Cabinet Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By End Use

      • 6.5.10. Rest of LAMEA Biological Safety Cabinet Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By End Use

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Labconco Corp.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Thermo Fisher Scientific, Inc.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. The Baker Company, Inc.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. NuAire

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Jinan Biobase Biotech Co. Ltd.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. AZBIL TELSTAR, S.L.U.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Air Science USA LLC

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Germfree Laboratories, Inc.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Haier Biomedical (Qingdao Biomedical Co., Ltd.)

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Cruma S.A.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SAFETY CABINET MARKET FOR CLASS I, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET FOR CLASS II, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET FOR CLASS III, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET FOR DIAGNOSTICS AND TESTING LABORATORIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET FOR ACADEMIC AND RESEARCH ORGANIZATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA BIOLOGICAL SAFETY CABINET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 13. U.S. BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 14. U.S. BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 15. CANADA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 16. CANADA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE BIOLOGICAL SAFETY CABINET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 26. ITALY BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 27. ITALY BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 30. UK BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 31. UK BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 39. CHINA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 40. CHINA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 43. INDIA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. INDIA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA BIOLOGICAL SAFETY CABINET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 66. UAE BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 67. UAE BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA BIOLOGICAL SAFETY CABINET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA BIOLOGICAL SAFETY CABINET, BY END USE, 2025-2033 ($MILLION)
  • TABLE 72. LABCONCO CORP.: KEY EXECUTIVES
  • TABLE 73. LABCONCO CORP.: COMPANY SNAPSHOT
  • TABLE 74. LABCONCO CORP.: OPERATING SEGMENTS
  • TABLE 75. LABCONCO CORP.: PRODUCT PORTFOLIO
  • TABLE 76. LABCONCO CORP.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 77. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 78. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 79. THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
  • TABLE 80. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
  • TABLE 81. THERMO FISHER SCIENTIFIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. THE BAKER COMPANY, INC.: KEY EXECUTIVES
  • TABLE 83. THE BAKER COMPANY, INC.: COMPANY SNAPSHOT
  • TABLE 84. THE BAKER COMPANY, INC.: OPERATING SEGMENTS
  • TABLE 85. THE BAKER COMPANY, INC.: PRODUCT PORTFOLIO
  • TABLE 86. THE BAKER COMPANY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. NUAIRE: KEY EXECUTIVES
  • TABLE 88. NUAIRE: COMPANY SNAPSHOT
  • TABLE 89. NUAIRE: OPERATING SEGMENTS
  • TABLE 90. NUAIRE: PRODUCT PORTFOLIO
  • TABLE 91. NUAIRE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. JINAN BIOBASE BIOTECH CO. LTD.: KEY EXECUTIVES
  • TABLE 93. JINAN BIOBASE BIOTECH CO. LTD.: COMPANY SNAPSHOT
  • TABLE 94. JINAN BIOBASE BIOTECH CO. LTD.: OPERATING SEGMENTS
  • TABLE 95. JINAN BIOBASE BIOTECH CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 96. JINAN BIOBASE BIOTECH CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. AZBIL TELSTAR, S.L.U.: KEY EXECUTIVES
  • TABLE 98. AZBIL TELSTAR, S.L.U.: COMPANY SNAPSHOT
  • TABLE 99. AZBIL TELSTAR, S.L.U.: OPERATING SEGMENTS
  • TABLE 100. AZBIL TELSTAR, S.L.U.: PRODUCT PORTFOLIO
  • TABLE 101. AZBIL TELSTAR, S.L.U.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. AIR SCIENCE USA LLC: KEY EXECUTIVES
  • TABLE 103. AIR SCIENCE USA LLC: COMPANY SNAPSHOT
  • TABLE 104. AIR SCIENCE USA LLC: OPERATING SEGMENTS
  • TABLE 105. AIR SCIENCE USA LLC: PRODUCT PORTFOLIO
  • TABLE 106. AIR SCIENCE USA LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. GERMFREE LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 108. GERMFREE LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 109. GERMFREE LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 110. GERMFREE LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 111. GERMFREE LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. HAIER BIOMEDICAL (QINGDAO BIOMEDICAL CO., LTD.): KEY EXECUTIVES
  • TABLE 113. HAIER BIOMEDICAL (QINGDAO BIOMEDICAL CO., LTD.): COMPANY SNAPSHOT
  • TABLE 114. HAIER BIOMEDICAL (QINGDAO BIOMEDICAL CO., LTD.): OPERATING SEGMENTS
  • TABLE 115. HAIER BIOMEDICAL (QINGDAO BIOMEDICAL CO., LTD.): PRODUCT PORTFOLIO
  • TABLE 116. HAIER BIOMEDICAL (QINGDAO BIOMEDICAL CO., LTD.): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. CRUMA S.A.: KEY EXECUTIVES
  • TABLE 118. CRUMA S.A.: COMPANY SNAPSHOT
  • TABLE 119. CRUMA S.A.: OPERATING SEGMENTS
  • TABLE 120. CRUMA S.A.: PRODUCT PORTFOLIO
  • TABLE 121. CRUMA S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SEGMENTATION
  • FIGURE 2. GLOBAL BIOLOGICAL SAFETY CABINET MARKET
  • FIGURE 3. SEGMENTATION BIOLOGICAL SAFETY CABINET MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN BIOLOGICAL SAFETY CABINET MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBIOLOGICAL SAFETY CABINET MARKET
  • FIGURE 11. BIOLOGICAL SAFETY CABINET MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. BIOLOGICAL SAFETY CABINET MARKET FOR CLASS I, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. BIOLOGICAL SAFETY CABINET MARKET FOR CLASS II, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. BIOLOGICAL SAFETY CABINET MARKET FOR CLASS III, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. BIOLOGICAL SAFETY CABINET MARKET SEGMENTATION, BY BY END USE
  • FIGURE 16. BIOLOGICAL SAFETY CABINET MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. BIOLOGICAL SAFETY CABINET MARKET FOR DIAGNOSTICS AND TESTING LABORATORIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. BIOLOGICAL SAFETY CABINET MARKET FOR ACADEMIC AND RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 23. COMPETITIVE DASHBOARD
  • FIGURE 24. COMPETITIVE HEATMAP: BIOLOGICAL SAFETY CABINET MARKET
  • FIGURE 25. TOP PLAYER POSITIONING, 2024
  • FIGURE 26. LABCONCO CORP.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 27. LABCONCO CORP.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 28. LABCONCO CORP.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 29. THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. THE BAKER COMPANY, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. THE BAKER COMPANY, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. THE BAKER COMPANY, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. NUAIRE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. NUAIRE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. NUAIRE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. JINAN BIOBASE BIOTECH CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. JINAN BIOBASE BIOTECH CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. JINAN BIOBASE BIOTECH CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. AZBIL TELSTAR, S.L.U.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. AZBIL TELSTAR, S.L.U.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. AZBIL TELSTAR, S.L.U.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. AIR SCIENCE USA LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. AIR SCIENCE USA LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. AIR SCIENCE USA LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. GERMFREE LABORATORIES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. GERMFREE LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. GERMFREE LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. HAIER BIOMEDICAL (QINGDAO BIOMEDICAL CO., LTD.): NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. HAIER BIOMEDICAL (QINGDAO BIOMEDICAL CO., LTD.): REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. HAIER BIOMEDICAL (QINGDAO BIOMEDICAL CO., LTD.): REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. CRUMA S.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. CRUMA S.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. CRUMA S.A.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Biological Safety Cabinet Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved